162 results
Page 2 of 9
8-K
EX-1.1
f243e08h ft6t0g2a
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
424B5
xn5p2f35cd evnthkwcc
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-99.1
5cjdj2iofy rn0ogt
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
uxgtm9nlgkj 1m
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-10.2
bvww bpnx
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-4.1
d014o1sy72jjc50mpae7
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.3
urc8y qldzc
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-99.1
5wq9ns6wa74k ykd8
21 May 21
Larimar Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for CTI-1601 in Friedreich’s Ataxia
7:28am